Potential clinical and sexual factors associated with Actinomyces spp. in a service of Pap smear, Medellin 2013-2014

Potenciales factores clínicos y sexuales asociados con Actinomyces spp. en un servicio de citología cérvico-uterina de Medellín 2013-2014

Published 2016-12-31


https://doi.org/10.30554/archmed.16.2.1719.2016
Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 16 No. 2
Section
Research Articles
How to Cite
Arango Garzón, J. S., Rodríguez Osorio, J., Restrepo Adarve, A. C., Sandoval Mazo, D. M., Valencia Arredondo, M., & Cardona Arias, J. A. (2016). Potential clinical and sexual factors associated with Actinomyces spp. in a service of Pap smear, Medellin 2013-2014. Archivos De Medicina (Manizales), 16(2), 267-278. https://doi.org/10.30554/archmed.16.2.1719.2016
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.16.2.1719.2016
Dimensions
PlumX

How to Cite

Arango Garzón, J. S., Rodríguez Osorio, J., Restrepo Adarve, A. C., Sandoval Mazo, D. M., Valencia Arredondo, M., & Cardona Arias, J. A. (2016). Potential clinical and sexual factors associated with Actinomyces spp. in a service of Pap smear, Medellin 2013-2014. Archivos De Medicina (Manizales), 16(2), 267-278. https://doi.org/10.30554/archmed.16.2.1719.2016

Download Citation

license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Johny Steven Arango Garzón
Juliana Rodríguez Osorio
Ana Catalina Restrepo Adarve
Diana Marcela Sandoval Mazo
Marleny Valencia Arredondo
Jaiberth Antonio Cardona Arias
Show authors biography

Jaiberth Antonio Cardona Arias,

MSc Epidemiología. (c)MSc Economía aplicada

Most read articles by the same author(s)

Objective: To determine the potential clinical and sexual factors associated with infection by Actinomyces spp., in patients service of Pap smear of a social enterprise of state of subsidized regime of Medellin. Methods: Cross-sectional study conducted with 27,576 cytological records collected from 2013 to 2014. Data were analyzed in SPSS 22, with summary measures, frequencies, and nonparametric statistic, a p value less than 0.05 was considered statistically significant. The confounding factors were controlled with binary logistic regression models. Results: The overall prevalence of Actinomyces spp., was 0.4%. Specific prevalences were higher in the group of women aged between 21 and 50 years. The factors that presented statistical association with infection were the planning method, smoking and cytology findings of inflammation. The odds ratio of infection among women who used IUD was 268 times higher and using a barrier method users was 7 times higher, in compared to women who do not used any planning method; in women who was not smoke 1.8 times higher compared to those who smoke, and 2.5 in women without atrophy in the oncological evaluation compared those who did not present this finding. Conclusion: The prevalence of Actinomyces spp. it was higher in adult women between 21 and 50 years, and potential clinical and sexual factors found were: being IUD user, do not present atrophy, do not consume snuff and use the barrier method. These Findings therefore require analytical studies that may account for these results, in addition to address and strengthen education programs and health care front to infection by this organism, this reveals the importance of descriptive research the formulation of new hypotheses.

Article visits | PDF visits

Downloads

Download data is not yet available.
  1. López J, Gasull J, Vivar B. Actinomyces e infecciones mixtas en la citología cervicovaginal, en portadoras de DIU. Clin Invest Ginecol Obstet 2010; 37(4):134–40.
  2. Kim Y, Youm J, Kim J, Jee B. Actinomyces-like organisms in cervical smears: the association with intrauterine device and pelvic inflammatory diseases. Obstet Gynecol Sci 2014; 57(5):393–6.
  3. Rojas B, Guardia L, Arribas T, Ania A, González I, Chipana M, et al. Actinomicosis de pared abdominal. A propósito de un caso. Cir Cir 2015; 83(2):141–5.
  4. Kononen E, Wade W. Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015; 28(1098-6618 (Electronic)):419–42.
  5. Florez A, Parrilla I, Urdes E, Quintana V, Gutiérrez V. Prevención, diagnóstico y tratamiento de actinomicosis en el adulto. Cenetec salud 2010.
  6. Sánchez J, Mercado N, Chilaca F, Rivera J. Uso del DIU asociado a la infección secundaria por Actinomyces en tracto genital femenino. Rev española Patol 2004; 37:383–9.
  7. Elsayed S, George a, Zhang K. Intrauterine contraceptive device-associated pelvic actinomycosis caused by Actinomyces urogenitalis. Anaerobe 2006; 12(2):67–70.
  8. Jonas L, Baguhl F, Wilken H. Copper accumulation in Actinomyces druses during endometritis after long-term use of an intrauterine. Ultrastruct Pathol 2002; 26:323–9.
  9. Jones J, Kaplan W, Brown J, White W. Studies of cervicovaginal smears for the presence of actinomycetes. Mycopathologia 1983; 83(1):53–5.
  10. Madrid F, Diaz S, Mucientes F, Klaassen R. Actinomicosis ginecologica. Rev Chil Obstet Ginecol 2003; 68(1):21–7.
  11. Cardona J, Herrera D, Valencia M. Prevalence of Actinomyces spp. and distribution according to demographic and clinical factores, Medellín Colombia 2010-2012. iMedPub Journals 2015; 11:1–9.
  12. Lucas J, Dick V, Leo S, Anneke B, Mario V, Peter V. Clinical Spectrum of Infections Due to the Newly Described Actinomyces Species A. turicensis, A. radingae, and A. europaeus. J Clin Microbiol 1999; 37: 8-13.
  13. Persson E, Holmberg K. Longitudinal Study of Actinomyces israelii in the Female Genital Tract. Acta Obstet Gynecol Scand 1984; 63: 207-16.
  14. Moreno D. Osteomielitis mandibular por actinomices: Reporte de caso. Rev Estomatol Hered 2012; 22:223–7.
  15. Bello Y, Ojeda P, Mosquera Ó, Martínez F, Lozano A. Actinomicosis del sistema nervioso central: presentación de caso. Rev Colomb Radiol 2013; 24(4):3827–31.
  16. Arenas A, Osorio Y, Cardona J. Prevalence of vaginal Actinomycosis and its association with the use of the intrauterine device in three health institutions in Antioquia, 2013. CES Med 2015; 29(1):47–58.
  17. Aznar J, Blanco M, Lepe J, Otero L, Vázquez F. Diagnóstico microbiológico de las infecciones de transmisión sexual y otras infecciones genitales. Enferm Infecc Microbiol Clin 2007; 26(1):32–7.
  18. Bustos G, Josa D, Perea J. Asociación Colombiana de Infectología Enfermedad pélvica inflamatoria por Actinomyces sp. en paciente con dispositivo intrauterino: reporte de un caso. Infect 2016; 20(1):33–6.
  19. Bessenay F, Bonnier P, Caben D, Crebassa E, Charpin C, Piana L. Pelvic Tumoral Actinomycosis, A Difficult Diagnosis, two cases reports. Contracept Fertil Sex 1999; 27: 56-60.
  20. Dayan K., Neufeld D., Zissin R., Bernheim J., Paran H., Schwartz I., et al. Actinomycocis of the large bowel: unusual presentations and their surgical treatment. Eur J Surg. 1996, 162: 657 – 60.
  21. Hinnie J., Jackes Bc., Bell E., Hansell Dt., Millroy R. Actinomycosis presenting as carcinoma. Postgrad Med J.1995; 71: 749-50.
  22. Gupta, P, McGrath, C. Microbiology, Inflammation, and Viral infections. In: Bibbo M, Wilbur D. Comprehensive Cytopathology. 3th edn. Philadelphia: Saunders Company 2008: 91- 129.
  23. Restrepo J, Mejía A, Valencia M, Tamayo L, Salas W. Accesibilidad a la citología cervical en Medellín, Colombia en 2006. Rev Esp Salud Pública 2007; 81(6): 657-666.
  24. Gupta P, Hollander D, Frost J. Actinomycetes in cervico-vaginal smears: an association with IUD usage. Acta Cytol 1976; 20(4):295—297.
  25. Solomon D, Nayar R. El sistema Bethesda 2001, para informar la citología cervical. Definiciones, criterios y nota aclaratorios. Rev española Patol 2004; 37 (3): 341-42.
  26. Gupta P. Intrauterine contraceptive devices: vaginal cytology, pathologic changes and clinical implications. Acta Cytol 1982; 26(5):571—613.
  27. Chatwani A, Amin S. Management of intrauterine device-associated actinomycosis. Infect Dis Obstet Gynecol 1993; 1:130–3.
  28. Evans D. Actinomyces israelii in the female genital tract: a review. Genitourin Med 1993; 54–9.
  29. The American College of Obstetricians and Gynecologists. The intrauterine device. Int J Gynecol Obstet 1993; 41(2):189–93.
  30. Garrido G, Cogollo A, Rivera M, Sanjuan R, Diaz L. Prevalencia citológica de microorganismos compatibles con Actinomyces sp, entre usuarias del DIU. MedUNAB 1999; 2(6):120–3.
  31. Urbina S, Ruiz H, Parejas S. Pelvic actynomyces infection: report of two cases occurred in the Hospital of San José. Infect Dis Obstet Gynecol 2006; 69020:1–2.
  32. Mali B, Joshi J, Wagle U, Hazari K, Shah R, Chadha U, et al. Actinomyces in cervical smears of women using intrauterine contraceptive devices. Acta Cytol 1986; 30(4):367—371.
  33. Kalaichelvan V, Maw A, Singh K. Actinomyces in cervical smears of women using the intrauterine device in Singapore. Contraception 2006; 73(4):352–5.
  34. Sykes G, Shelley G. Actinomyces-like structures and their association with intrauterine contraceptive devices, pelvic infection and abnormal cervical cytology. BJOG 1981; 88(9):934–7.
  35. Pérez F. Female pelvic actinomycosis and intrauterine contraceptive devices. Open Access J Contracept. Dove Press 2010; 10(1):35–8.
  36. López J, Gasull J. Infección vaginal por tricomonas (e infecciones mixtas) y atipias celulares, en la citología cervicovaginal. Clin Invest Ginecol Obstet 2011; 38(4):120–7.
  37. López N, Castro M, Gamboa E, Vera L. Prevalencia y determinantes de las infecciones vaginales en las mujeres recluidas en una cárcel colombiana. Rev Chil Obstet Ginecol 2009; 74(2):77–82.
  38. Merchán J, Gómez H. Actinomicosis abdominal y pélvica: reto diagnóstico y quirúrgico para el cirujano general. Rev Colomb Cir 2010; 25:56–60.
  39. Bing A, Loh S, Morris T, Hughes H, Dixon J, Helgason K. Actinomyces Species Isolated from Breast Infections. J Clin Microbiol 2015; 53(10):3247–55.
  40. Perlow J, Wigton T, Yordan E, Graham J, Wool N, Wilbanks G. Disseminated pelvic actinomycosis presenting as metastatic carcinoma: association with the progestasert intrauterine device. Rev Infect Dis 1991; 13: 1115-9.

Information

Google Scholar Profile

Author Guidelines